B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

KMT5C

MOLECULAR TARGET

lysine methyltransferase 5C

UniProt: Q86Y97NCBI Gene: 847871 compounds

KMT5C (lysine methyltransferase 5C) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting KMT5C

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1s adenosylhomocysteine0.691

About KMT5C as a Drug Target

KMT5C (lysine methyltransferase 5C) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented KMT5C interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

KMT5C inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.